טוען...
JAK Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
Myelofibrosis (MF) is a manifestation of several disorders of hematopoiesis collectively referred to as myeloproliferative neoplasms (MPN). Allogeneic hematopoietic stem cell transplantation (ASCT) is the only therapy with proven curative potential. However, most patients with MF are in the 6(th) or...
שמור ב:
| הוצא לאור ב: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4465357/ https://ncbi.nlm.nih.gov/pubmed/24680977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.03.017 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|